Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of co-administration of
Teneligliptin (MP-513) and Canagliflozin (TA-7284) once daily for 52 weeks in Japanese
patients with Type 2 diabetes mellitus who are receiving treatment with Teneligliptin and
have inadequate glycemic control.